HC Wainwright & Co. Reiterates Buy on Imunon, Maintains $12 Price Target
Portfolio Pulse from richadhand@benzinga.com
HC Wainwright & Co. analyst Emily Bodnar has reiterated a 'Buy' rating on Imunon (NASDAQ:IMNN) and maintained a $12 price target.
August 11, 2023 | 2:30 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Imunon's stock rating has been reiterated as 'Buy' by HC Wainwright & Co. with a maintained price target of $12.
The reiteration of a 'Buy' rating by a reputable analyst firm like HC Wainwright & Co. is a positive signal for investors. The maintained price target of $12 indicates the firm's confidence in the stock's potential to reach this price, which could lead to an increase in investor interest and potentially a short-term increase in the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100